Home / Diabetes In Control (page 651)

Diabetes In Control

NIH Pulls Plug on AIM-HIGH Trial with Niaspan™

A trial of high-dose extended-release niacin (Niaspan, Abbott) given in addition to statin therapy in patients with a history of cardiovascular disease, high triglycerides, and low levels of HDL cholesterol has been halted prematurely, 18 months ahead of schedule, because niacin offered no additional benefits in this patient population….

Read More »